Caitong International Asset Management Co., Ltd
Position in ABT — Abbott Laboratories
CIK 1963355
HONG KONG, K3
Position in ABT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$783,372
+$584,606 QoQ
Shares Held
7,630
+414.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Caitong International Asset Management Co., Ltd holds $10,297,595 across 61 Medical Devices names. ABT ranks #3 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
97,766 | $6,134,816 | |
| 2 | DXCM |
Dexcom Inc
|
18,735 | $1,176,558 | |
| 3 | ABT |
Abbott Laboratories
This page
|
7,630 | $783,372 | |
| 4 | SYK |
Stryker Corp
|
1,704 | $559,917 | |
| 5 | TMDX |
TransMedics Group, Inc.
|
3,364 | $334,415 | |
| 6 | TNDM |
Tandem Diabetes Care Inc
|
14,245 | $273,076 | |
| 7 | BVS |
Bioventus Inc.
|
11,913 | $108,765 | |
| 8 | ATEC |
Alphatec Holdings, Inc.
|
9,505 | $103,414 |
All Filings in ABT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $783,372 | 7,630 | Shares | Sole | 2026-05-11 | |
| 2025-09-30 | $198,766 | 1,484 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $257,330 | 1,892 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,061 | 8 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $66,395 | 587 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||